Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

als, Inc. and Alkermes, Inc., submitted a reply to a complete response letter issued in October 2010 by FDA regarding Bydureon™, an investigational medication for type 2 diabetes. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date of January 28, 2012.
  • The company submitted its reply to a complete response letter by FDA regarding Amyvid™, a molecular Positron Emission Tomography (PET) imaging agent under investigation for the detection of beta-amyloid plaque in the brains of living patients.

  • The America Invents Act was signed into law, aligning new U.S. patent laws more closely with those from other countries and improving the global competiveness of U.S. innovator companies such as Lilly. The law will provide new advantages for U.S. inventors by streamlining the application process and addressing the backlog of current applications. This new law, which transitions the U.S. from a "first-to-invent" to a "first-inventor-to-file" system, is the most significant overhaul of the U.S. patent system in 175 years.

  • Third-Quarter Reported Results

    In the third quarter of 2011, worldwide total revenue was $6.148 billion, an increase of 9 percent compared with the third quarter of 2010. This 9 percent revenue growth was comprised of increases of 4 percent in volume and 4 percent due to the impact of foreign exchange rates. Price had a negligible impact on revenue growth, reflecting the loss of U.S. patent exclusivity for Gemzar® in November 2010. Total revenue in the U.S. increased 4 percent to $3.273 billion due to higher prices and increased volume. Total revenue outside the U.S. increased 15 percent to $2.874 billion due to the positive impact of foreign exchange rates and increased volume. Third-quarter 2011 total revenue was reduced by approximately $130 million due to the impact of U.S. health care reform.

    Gross margin increased 3.1 percent to $4.810 billion in the third quarte
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Lilly Declares Fourth-Quarter 2011 Dividend
    2. Lilly Announces Changes in Senior Management
    3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
    4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
    5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
    6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
    7. Lilly Health Channel Debuts on YouTube
    8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
    9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
    10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
    11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/4/2015)... , March 4, 2015 Perrigo Company plc (NYSE: ... President and CEO Joseph C. Papa will present ... on Wednesday, March 11, 2015 at the Loews Miami Beach ... can access the presentation webcast at http://perrigo.investorroom.com/events-webcasts . ... remedies in 1887, Perrigo Company plc, headquartered in ...
    (Date:3/4/2015)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced ... Conference at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give ... of ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation ... and available through the link through June 7, 2015. ...
    (Date:3/3/2015)... , March 3, 2015  Vermillion, Inc. (NASDAQ: ... disease, today announced management will present at the 27 th ... Ritz-Carlton in Dana Point, California from ... CEO of Vermillion, Valerie Palmieri , will be presenting ... be joined by Eric Schoen , the company,s Vice ...
    Breaking Medicine Technology:Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2Vermillion To Present at 27th Annual ROTH Conference on March 9 2
    (Date:3/4/2015)... 2015 Today Visiopharm announces that Patrik ... joined the Visiopharm Board of Directors as ... when we are positioned to become the fastest growing ... diagnostics and research. , "Over the last ... and validation of ONCOtopix™ Dx, a complete quantitative digital ...
    (Date:3/4/2015)... FL (PRWEB) March 04, 2015 Problem ... the time to join individuals and organizations across the ... the general public, health care professionals, policymakers, and others ... Florida Council on Compulsive Gambling (FCCG) and FCCG partner ... communities to screen patients for a gambling problem, to ...
    (Date:3/4/2015)... (PRWEB) March 04, 2015 A new ... showing promise in terms of extending life. Studies ... that this new dieting routine can help extend life ... production clearly has long term benefits, many suffering from ... a quicker substitute is necessary. As an alternative to ...
    (Date:3/4/2015)... 2015 Dietary supplement company MitoSynergy ... first biocompatible copper chelate, at Natural Products Expo West ... chance to gain insight into their wellness through a ... complex can support their individual nutritional needs, all while ... the core ingredient of the MitoSynergy product line, was ...
    (Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... devices that are used to draw milk from the breast ... the purpose of storage and use for feeding the baby. ... due to medical complications, premature birth, or the mother being ... day because of work, among others. Breast pumps are also ...
    Breaking Medicine News(10 mins):Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Problem Gambling - A Public Health Issue; March Is Problem Gambling Awareness Month 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3Health News:MitoSynergy Invites Expo West Attendees to Sit Back, Relax and Take Time for Their Health 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 3
    ... might lead to lab-grown eyes, they say , WEDNESDAY, Oct. ... cellular signal that switches on eye development. , They said ... connected to eye formation. , The findings of the study, ... Nature , could be the start of a new line ...
    ... Late-breaking data presented at TCT 2007, the scientific ... the use of the anticoagulant bivalirudin following angioplasty in ... 24 percent compared to the standard treatment, and significantly ... percent. , Results of the HORIZONS AMI trial, ...
    ... at UCL (University College London) have developed a more ... age-related macular disease (AMD), the leading cause of blindness ... on a visual illusion, could lead to earlier self-diagnosis ... assistance earlier on and potentially delay loss of vision. ...
    ... The medical director of the,world-renowned Los Angeles Jewish Home ... elderly in the area as a result of,the multiple ... that though no one is immune to the effects,these ... more sensitive. He,offered several pragmatic health tips to deal ...
    ... Oct. 24 /Xinhua-PRNewswire-FirstCall/,-- Genesis Technology Group Inc. ... as,Genesis Pharmaceutical Enterprises, Inc.) ("GTEC" or "the ... Republic of China ("PRC"),today announced that it ... execute its,investor relations campaign. Genesis, through ...
    ... Pharmaceutical,Laboratories, Ltd. (Amex: CPD ) posted record net ... fiscal 2008, ended September 30, 2007, of,$41.4 million and ... million for the corresponding periods of fiscal 2007. This,represents ... and first six,months of fiscal 2007, respectively. Net income ...
    Cached Medicine News:Health News:HORIZONS AMI trial data will help set guidelines 2Health News:'Twinkle' eye test could improve AMD diagnosis 2Health News:Medical Director of Famed Los Angeles Jewish Home Gives Tips to Elderly for Coping With Effects of Southland Fires 2Health News:Genesis Technology Group Retains CCG Elite 2Health News:Genesis Technology Group Retains CCG Elite 3Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 2Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 3Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 4Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 5Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 6Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 7
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: